ACCC Recognizes Ethan Basch on Symptom Monitoring in Oncology
In Partnership With
Ethan Basch, MD, MSc, recently received the Clinical Research Award from the Association of Community Cancer Centers during the 2019 National Oncology Conference. Basch explains the importance of receiving this award in light of his work around patient-reported outcomes for symptom monitoring in oncology.
Ethan Basch, MD, MSc, director, Cancer Outcomes Research Program, and Richard M. Goldberg Distinguished Professor in Medical Oncology, UNC Lineberger Comprehensive Cancer Center, recently received the Clinical Research Award from the Association of Community Cancer Centers (ACCC) during the 2019 National Oncology Conference. Basch explains the importance of receiving this award in light of his work around patient-reported outcomes for symptom monitoring in oncology.
The idea of completing a questionnaire for symptom monitoring was not thought of by providers 15 years ago, says Basch. Today, more providers are monitoring patients, communicating with patients, and catching symptoms early. These concepts have now come into the forefront of how providers coordinate, manage, and navigate care.
Enasidenib Shows Promise as Post-Transplant Maintenance in IDH2-Mutated AML
January 7th 2025Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic stem cell transplant maintenance therapy for IDH2-mutated acute myeloid leukemia treatment.
Read More
Could Triapine With Lutetium 177 Dotatate Improve Outcomes for Neuroendocrine Tumors?
December 30th 2024Aman Chauhan, MD, highlights an ongoing phase 2 trial exploring the combination of triapine, a radiation sensitizer, with lutetium 177 dotatate for treating well-differentiated somatostatin receptor–-positive neuroendocrine tumors.
Read More
